Follow
David Roberge
David Roberge
Université de Montréal / McGill
Verified email at ssss.gouv.qc.ca
Title
Cited by
Cited by
Year
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ...
Journal of Clinical Oncology 30 (4), 419, 2012
14632012
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients
PW Sperduto, ST Chao, PK Sneed, X Luo, J Suh, D Roberge, A Bhatt, ...
International Journal of Radiation Oncology* Biology* Physics 77 (3), 655-661, 2010
10782010
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC· 3): a multicentre, randomised, controlled …
PD Brown, KV Ballman, JH Cerhan, SK Anderson, XW Carrero, ...
The Lancet Oncology 18 (8), 1049-1060, 2017
10342017
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
PD Brown, S Pugh, NN Laack, JS Wefel, D Khuntia, C Meyers, A Choucair, ...
Neuro-oncology 15 (10), 1429-1437, 2013
9012013
Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA)
PW Sperduto, TJ Yang, K Beal, H Pan, PD Brown, A Bangdiwala, ...
JAMA oncology 3 (6), 827-831, 2017
6152017
Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001
PD Brown, V Gondi, S Pugh, WA Tome, JS Wefel, TS Armstrong, JA Bovi, ...
Journal of Clinical Oncology 38 (10), 1019, 2020
6062020
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ...
International Journal of Radiation Oncology* Biology* Physics 82 (5), 2111-2117, 2012
4042012
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ...
International Journal of Radiation Oncology* Biology* Physics 82 (5), 2111-2117, 2012
4012012
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
ME Robson, PO Chappuis, J Satagopan, N Wong, J Boyd, JR Goffin, ...
Breast Cancer Research 6, 1-10, 2003
3542003
Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient
PW Sperduto, S Mesko, J Li, D Cagney, A Aizer, NU Lin, E Nesbit, ...
Journal of clinical oncology 38 (32), 3773, 2020
2712020
The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy
A Sahgal, D Roberge, D Schellenberg, TG Purdie, A Swaminath, ...
Clinical oncology 24 (9), 629-639, 2012
2572012
Estimating survival in melanoma patients with brain metastases: an update of the graded prognostic assessment for melanoma using molecular markers (Melanoma-molGPA)
PW Sperduto, W Jiang, PD Brown, S Braunstein, P Sneed, DA Wattson, ...
International Journal of Radiation Oncology* Biology* Physics 99 (4), 812-816, 2017
1892017
Principles and practice of stereotactic radiosurgery
LS Chin, WF Regine
Springer Science & Business Media, 2010
1842010
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
PW Sperduto, N Kased, D Roberge, ST Chao, R Shanley, X Luo, ...
Journal of neuro-oncology 112, 467-472, 2013
1832013
Adult cerebellar medulloblastomas: the pathological, radiographic, and clinical disease spectrum
JL Hubbard, BW Scheithauer, DB Kispert, SM Carpenter, MR Wick, ...
Journal of neurosurgery 70 (4), 536-544, 1989
1821989
Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine
D Curman, B Cinel, DE Williams, N Rundle, WD Block, AA Goodarzi, ...
Journal of Biological Chemistry 276 (21), 17914-17919, 2001
1652001
Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma
D Roberge, T Skamene, A Nahal, RE Turcotte, T Powell, C Freeman
Radiotherapy and oncology 97 (3), 404-407, 2010
1432010
Intensity-modulated radiotherapy for craniospinal irradiation: target volume considerations, dose constraints, and competing risks
W Parker, E Filion, D Roberge, CR Freeman
International Journal of Radiation Oncology* Biology* Physics 69 (1), 251-257, 2007
1302007
Treatment guidelines for preoperative radiation therapy for retroperitoneal sarcoma: preliminary consensus of an international expert panel
EH Baldini, D Wang, RLM Haas, CN Catton, DJ Indelicato, DG Kirsch, ...
International Journal of Radiation Oncology* Biology* Physics 92 (3), 602-612, 2015
1212015
FDG PET/CT in initial staging of adult soft-tissue sarcoma
D Roberge, S Vakilian, YZ Alabed, RE Turcotte, CR Freeman, M Hickeson
Sarcoma 2012, 2012
1092012
The system can't perform the operation now. Try again later.
Articles 1–20